Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FORTIS.NS Stock Summary
Top 10 Correlated ETFs
FORTIS.NS
In the News
FORTIS.NS Financial details
Company Rating
Buy
Market Cap
305.53B
Income
5.53B
Revenue
67.5B
Book val./share
112.33
Cash/share
4.53
Dividend
1
Dividend %
0.24%
Employees
13.01K
Optionable
No
Shortable
Yes
Earnings
21 May 2024
P/E
58.46
Forward P/E
38.48
PEG
-1432.27
P/S
4.83
P/B
4.21
P/C
92.76
P/FCF
-
Quick Ratio
0.37
Current Ratio
0.43
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
7.32
EPS next Y
10.92
EPS next Q
1.94
EPS this Y
6.12%
EPS next Y
49.24%
EPS next 5Y
87.97%
EPS last 5Y
NAN%
Revenue last 5Y
7.5%
Revenue Q/Q
-5.1%
EPS Q/Q
-22.61%
-
-
-
-
SMA20
-6.47%
SMA50
-4.26%
SMA100
23.1%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
15%
ROC
0.09%
Gross Margin
56%
Oper. Margin
13%
Profit Margin
8%
Payout
-
Shs Outstand
754.96M
Shs Float
477.01M
-
-
-
-
Target Price
-
52W Range
245.5-469.7
52W High
-10.41%
52W Low
+71.51%
RSI
54
Rel Volume
0.88
Avg Volume
1.52M
Volume
1.33M
Perf Week
4.72%
Perf Month
-1.25%
Perf Quarter
28.15%
Perf Half Y
26.49%
-
-
-
-
Beta
0.632
-
-
Volatility
7.17%, 19.21%
Prev Close
1.69%
Price
420.2
Change
1.27%
FORTIS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 72.07 | 59.7 | 52.47 | 74.69 | 83.42 | |
Net income per share | -4.91 | 0.77 | -1.45 | 7.35 | 7.8 | |
Operating cash flow per share | -2.93 | 2.27 | 6.43 | 11.46 | 10.89 | |
Free cash flow per share | -4.3 | 0.21 | 3.54 | 8.61 | 4.97 | |
Cash per share | 15.36 | 3.52 | 5.52 | 5.46 | 5.22 | |
Book value per share | 108.44 | 88.23 | 81.06 | 81.84 | 95.93 | |
Tangible book value per share | 54.23 | 45.15 | 38.84 | 33.68 | 46.67 | |
Share holders equity per share | 108.44 | 88.23 | 81.06 | 81.84 | 95.93 | |
Interest debt per share | 37.75 | 23.5 | 22.24 | 18.31 | 13.97 | |
Market cap | 83.15B | 95.24B | 150.35B | 219.24B | 196.21B | |
Enterprise value | 95.31B | 109.36B | 163.04B | 230.36B | 204.06B | |
P/E ratio | -27.81 | 164.38 | -136.98 | 39.49 | 33.33 | |
Price to sales ratio | 1.9 | 2.11 | 3.8 | 3.89 | 3.12 | |
POCF ratio | -46.57 | 55.52 | 30.97 | 25.33 | 23.86 | |
PFCF ratio | -31.78 | 608.23 | 56.31 | 33.73 | 52.32 | |
P/B Ratio | 1.26 | 1.43 | 2.46 | 3.55 | 2.71 | |
PTB ratio | 1.26 | 1.43 | 2.46 | 3.55 | 2.71 | |
EV to sales | 2.17 | 2.43 | 4.12 | 4.09 | 3.24 | |
Enterprise value over EBITDA | 17.24 | 16.25 | 34 | 21.14 | 17.22 | |
EV to operating cash flow | -53.39 | 63.75 | 33.58 | 26.62 | 24.82 | |
EV to free cash flow | -36.43 | 698.44 | 61.07 | 35.44 | 54.42 | |
Earnings yield | -0.04 | 0.01 | -0.01 | 0.03 | 0.03 | |
Free cash flow yield | -0.03 | 0 | 0.02 | 0.03 | 0.02 | |
Debt to equity | 0.3 | 0.24 | 0.25 | 0.2 | 0.13 | |
Debt to assets | 0.17 | 0.14 | 0.14 | 0.11 | 0.07 | |
Net debt to EBITDA | 2.2 | 2.1 | 2.65 | 1.02 | 0.66 | |
Current ratio | 0.46 | 0.36 | 0.84 | 0.89 | 0.99 | |
Interest coverage | 0.14 | 1.73 | 0.8 | 5.97 | 6.08 | |
Income quality | 1.62 | 0.72 | 11.21 | 0.88 | 1.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0.03 | |
Sales general and administrative to revenue | 0.05 | 0.03 | 0.03 | 0.22 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.32 | 0.33 | 0.34 | 0.38 | 0.37 | |
Capex to operating cash flow | 0.47 | -0.91 | -0.45 | -0.25 | -0.54 | |
Capex to revenue | -0.02 | -0.03 | -0.06 | -0.04 | -0.07 | |
Capex to depreciation | -0.36 | -0.53 | -0.75 | -0.72 | -1.42 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 109.46 | 39.03 | 51.49 | 116.36 | 129.74 | |
ROIC | 0.01 | 0.01 | -0.02 | 0.08 | 0.07 | |
Return on tangible assets | -0.04 | 0.01 | -0.01 | 0.07 | 0.07 | |
Graham Net | -55.53 | -45.19 | -47.52 | -52.46 | -43.02 | |
Working capital | -19.24B | -16.38B | -1.96B | -1.36B | -195.3M | |
Tangible asset value | 33.01B | 34.09B | 29.32B | 25.43B | 35.23B | |
Net current asset value | -31.72B | -32.02B | -34B | -37.43B | -29.27B | |
Invested capital | 0.3 | 0.24 | 0.25 | 0.2 | 0.13 | |
Average receivables | 3.3B | 6.14B | 5.47B | 5.58B | 7.14B | |
Average payables | 7.68B | 6.76B | 5.73B | 6.05B | 6.88B | |
Average inventory | 615.81M | 673.56M | 774.71M | 998.32M | 1.23B | |
Days sales outstanding | 54.97 | 45.96 | 48.48 | 38.17 | 48.64 | |
Days payables outstanding | 127.48 | 107.88 | 108.51 | 170.13 | 94.25 | |
Days of inventory on hand | 9.56 | 14.11 | 15.19 | 31.64 | 16.21 | |
Receivables turnover | 6.64 | 7.94 | 7.53 | 9.56 | 7.5 | |
Payables turnover | 2.86 | 3.38 | 3.36 | 2.15 | 3.87 | |
Inventory turnover | 38.16 | 25.86 | 24.02 | 11.54 | 22.52 | |
ROE | -0.05 | 0.01 | -0.02 | 0.09 | 0.08 | |
Capex per share | -1.37 | -2.06 | -2.89 | -2.85 | -5.92 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 20.71 | 21.81 | 21.95 | 23.44 | 22.25 | |
Net income per share | 1.72 | 1.76 | 1.48 | 2.3 | 1.78 | |
Operating cash flow per share | 2.2 | 2.17 | 2.1 | 2.23 | 2.3 | |
Free cash flow per share | 2.2 | 2.17 | 2.1 | 2.23 | 2.3 | |
Cash per share | 4.66 | 5.24 | 4.85 | 5.11 | 4.53 | |
Book value per share | 103.39 | 96.16 | 107.3 | 100.8 | 112.33 | |
Tangible book value per share | 0 | 46.78 | 0 | 51.42 | 0 | |
Share holders equity per share | 103.39 | 96.16 | 107.3 | 100.8 | 112.33 | |
Interest debt per share | 0.44 | 12.71 | 0.42 | 14.1 | 0.44 | |
Market cap | 215.51B | 195.74B | 237.85B | 256.65B | 331.88B | |
Enterprise value | 219.02B | 203.58B | 241.51B | 266.07B | 335.3B | |
P/E ratio | 41.58 | 36.92 | 53.21 | 36.93 | 61.61 | |
Price to sales ratio | 13.82 | 11.92 | 14.35 | 14.5 | 19.76 | |
POCF ratio | 130.22 | 119.67 | 150.08 | 152.55 | 190.93 | |
PFCF ratio | 130.22 | 119.67 | 150.08 | 152.55 | 190.93 | |
P/B Ratio | 2.77 | 2.7 | 2.94 | 3.37 | 3.91 | |
PTB ratio | 2.77 | 2.7 | 2.94 | 3.37 | 3.91 | |
EV to sales | 14.04 | 12.39 | 14.57 | 15.03 | 19.96 | |
Enterprise value over EBITDA | 75.33 | 71.09 | 86.26 | 77.13 | 113.54 | |
EV to operating cash flow | 132.34 | 124.47 | 152.39 | 158.15 | 192.9 | |
EV to free cash flow | 132.34 | 124.47 | 152.39 | 158.15 | 192.9 | |
Earnings yield | 0.01 | 0.01 | 0 | 0.01 | 0 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0 | 0.13 | 0 | 0.14 | 0 | |
Debt to assets | 0 | 0.07 | 0 | 0.08 | 0 | |
Net debt to EBITDA | 1.21 | 2.74 | 1.31 | 2.73 | 1.16 | |
Current ratio | 0 | 0.99 | 0 | 0.43 | 0 | |
Interest coverage | 6.23 | 6.45 | 6.14 | 8.2 | 6.32 | |
Income quality | 1.28 | 1.23 | 1.42 | 0.97 | 1.29 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.09 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.37 | 0 | 0.36 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 63.26 | 61.71 | 59.78 | 72.24 | 67.14 | |
ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Return on tangible assets | 0 | 0.02 | 0 | 0.02 | 0 | |
Graham Net | 4.66 | -43.13 | 4.85 | -44.2 | 4.53 | |
Working capital | 3.51B | -195.3M | 3.66B | -16.55B | 3.42B | |
Tangible asset value | 0 | 35.23B | 0 | 38.82B | 0 | |
Net current asset value | 3.51B | -29.27B | 3.66B | -30.46B | 3.42B | |
Invested capital | 0 | 0.13 | 0 | 0.14 | 0 | |
Average receivables | 3.15B | 4.2B | 4.2B | 3.47B | 3.47B | |
Average payables | 3.55B | 3.57B | 3.57B | 4.03B | 4.03B | |
Average inventory | 601.65M | 614.2M | 614.2M | 617.15M | 617.15M | |
Days sales outstanding | 0 | 45.98 | 0 | 35.32 | 0 | |
Days payables outstanding | 0 | 88.77 | 0 | 92.35 | 0 | |
Days of inventory on hand | 0 | 15.27 | 0 | 14.13 | 0 | |
Receivables turnover | 0 | 1.96 | 0 | 2.55 | 0 | |
Payables turnover | 0 | 1.01 | 0 | 0.97 | 0 | |
Inventory turnover | 0 | 5.9 | 0 | 6.37 | 0 | |
ROE | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
FORTIS.NS Frequently Asked Questions
What is Fortis Healthcare Limited stock symbol ?
Fortis Healthcare Limited is a IN stock and trading under the symbol FORTIS.NS
What is Fortis Healthcare Limited stock quote today ?
Fortis Healthcare Limited stock price is $420.2 today.
Is Fortis Healthcare Limited stock public?
Yes, Fortis Healthcare Limited is a publicly traded company.